Thyroid cancer Clinical Trials
Recruiting thyroid cancer studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.
Clinical trials study new ways to prevent, detect, or treat thyroid cancer. Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting thyroid cancer studies with sites across the US; use the location tools to find ones near you.
What to expect
- Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
- Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
- No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.
Recruiting thyroid cancer trials
Pre-Clinic Visit Online Education for Thyroid Cancer
FAPI PET Imaging - An Exploratory Study
Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk Stratification and Post-Treatment Surveillance in Fresh Thyroid Cancer Patients
177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer
Effectiveness of WeChat-Supported Neck Rehabilitation Exercises on Early Recovery After Thyroidectomy
Clinical Study on the Efficacy of Laparoscopic Assisted Open Surgery Through Subclavian Approach for Unilateral Thyroid Cancer
Pralsetinib DDI Study in Patients With Advanced or Metastatic Solid Tumors
A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors
Ganoderma Spores Modulate the Gut-Brain Axis
Anlotinib and Benmelstobart in DTC
Navigation Intervention for Adolescent and Young Adult Cancer Survivors
Postoperative Hypocalcemia After Thyroidectomy
Impact of Thyroid Hormones on Human Glucose and Energy Metabolism
Active Surveillance for Bethesda IV Thyroid Nodules
A Brief Video Intervention to Improve Patient Outcomes Following Radioiodine Treatment
Pharmaceutical Management in Targeted Radioligand Therapy
177Lu-CTR-FAPI for the Treatment of Thyroid Cancer
Development and Application of an AI Chatbot for Perioperative Health Education in Thyroid Cancer Patients
XP-102 and XP-102 in Combination With Trametinib in Advanced Solid Tumor Patients With a BRAF V600 Mutation
Response to Neoadjuvant Treatment in Locally Advanced Thyroid Cancer
Comparing the Therapeutic Efficacy of Extended Isthmusectomy Versus Total Thyroidectomy for Isthmus Tumors of the Thyroid
Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer
F-18 Tetrafluoroborate PET/CT in Differentiated Thyroid Cancer
Lenvatinib 24 mg/Day Versus 10 mg/Day to Treat Symptomatic or Progressive Radioactive Iodine Resistant (RAIR) Differentiated Thyroid Cancer (DTC)
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Evaluation of an Artificial Intelligence-enabled Clinical Assistant to Support Thyroid Cancer Management
DESTINY-PANTUMOUR04
Use of a Decision Aid to Resolve Uncertainty About Radioactive Iodine Treatment in Patients With Intermediate Risk Thyroid Cancer
Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery
Outcome of RAI131 Therapy in Patients With Differentiated Thyroid Cancer (Low and Intermediate Risk)
Prevalence and Predictors of Incidental Thyroid Carcinoma in Patients With Graves' Disease Undergoing Thyroidectomy.
Proteomic Analysis of Patients Undergoing Bariatric Surgery
XL092 and Cemiplimab in BRAF WT Thyroid Cancer
Necessity of TSH Suppression Therapy in Active Surveillance for Thyroid Cancer Patients.
Factors Influencing Inadequacy in Rapid Onsite Evaluation of Ultrasound Guided Fine Needle Aspiration (FNA) Samples of Thyroid Nodules
SLV-154 Treatment of Metastatic Solid Tumors
Shared Decision-Making for Determining Treatment Strategies in Low-Risk Thyroid Cancer
TRAIL Study: Feasibility and Pilot
Regret Emotion After Thyroidectomy in Low-Risk Papillary Thyroid Cancer
MRG003 and Pucotenlimab to Treat Locally Advanced or Metastatic ATC/PDTC
A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carcinoma
Sacituzumab Govitecan in Metastatic Salivary Gland and Thyroid Cancers (SG-SGTC)
18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis
Brodalumab in the Treatment of Immune-Related Adverse Events
Radiofrequency Ablation Versus Hemithyroidectomy of Small Thyroid Cancers
The Effect of Virtual Reality Applications
The Importance of Thymus Anatomy to the Radical Resection of Thyroid Cancer Surgery and the Protection of Parathyroid Function
Nasal Steam Therapy for Post-extubation Respiratory Events
The Value of 68Ga-FAPI PET/CT in Detecting Recurrent and Metastatic Lesions in Patients with Thyroid Cancer After Surgery
Mapping Patient Decision-making in Thyroid Cancer
This Study is Mainly About Finding Incidence Among Other Factors of Thyroid Cancer in Patient with Benign Disease As MNG to Early Discover of the Malignancy to Save the Patient from Aggressive Procedure
Trop2-targeted immunoPET Imaging of Solid Tumors
Patient-centered Dosage of Levothyroxine
To Perform a Post-market Study of the Performance of the Idylla ThyroidPrint Assay Using Clinical Samples in Predicting the Nature of Indeterminate Thyroid Nodules (ITNs) Across Multiple Centers.
Surgical Competency for Robot-Assisted Thyroidectomy: Construction and Validation of a Robotic Thyroidectomy Assessment Score (RTAS)
Global Real World Data in Patients With Advanced Thyroid Cancer on Standard of Care and Specialized Interventions- Registry of Oncologic Outcomes With Testing and Treatment.
Efficacy of Organoid-Based Chemotherapy Drug Precision Screening to Guide Treatment for Thyroid Cancer
The Value of 68Ga-FAPI PET/CT in Preoperative Evaluation of Thyroid Cancer with Lymph Node Metastases
Thyroid cancer clinical trials — common questions
Are thyroid cancer clinical trials free to join?
Yes. Participating in a thyroid cancer clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.
Who can join a thyroid cancer clinical trial?
Each thyroid cancer study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.
How do I find a thyroid cancer trial near me?
Use the location controls above. We'll show recruiting thyroid cancer trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.
How many thyroid cancer trials are recruiting right now?
We're currently tracking roughly 33 recruiting thyroid cancer trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.
Looking for a specific location? Browse trials by city and state.